NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024

F. Liu, Joyce; Berchuck, Andrew; Backes, Floor; G. Cohen, Joshua; N. Grisham, Rachel; A. Leath, Charles; P. Martin, Lainie; Matei, Daniela; S. Miller, David; E. Robertson, Sharon; Barroilhet, Lisa; Uppal, Shitanshu; Wahner Hendrickson, Andrea; M. Gershenson, David; J. Gray, Heidi; Hakam, Ardeshir; Jain, Angela; E. Konecny, Gottfried; W. Moroney, John; Ratner, Elena; O. Schorge, John; H. Thaker, Premal; L. Werner, Theresa; Zsíros, Emese; Behbakht, Kian; Chen, Lee-may; DeRosa, Marie; Eisenhauer, Eric; S. Leiserowitz, Gary; Litkouhi, Babak; McHale, Michael; Percac‐Lima, Sanja; J. Rodabaugh, Kerry; Vargas, Roberto; Jones, Frankie; Kovách, E; E. Hang, Lisa; Ramakrishnan, Swathi; D. Alvarez, Ronald; K. Armstrong, Deborah

doi:10.6004/jnccn.2024.0052

Public

NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024

Published in Journal of the National Comprehensive Cancer Network • Oct 1, 2024

Authors:

Joyce F. Liu

Andrew Berchuck

Floor Backes

Abstract

The NCCN Guidelines for Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer provide multidisciplinary diagnostic workup, staging, and treatment recommendations for this disease. These NCCN Guidelines Insights detail how the evolution of the use of PARP inhibitors as maintenance and single...

Subject

Medicine

Ovarian cancer

Fallopian tube

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!